Federal award
GALEN BIOTECHNOLOGIES, LLC
HDTRA113C0061
Contract
Obligated and Ceiling
- Obligated (net)
- $558,159.74
- Ceiling (potential value, not spending)
- $558,159.74
- Current value
- $558,159.74
- Gross positive obligations
- $573,510.87
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- GALEN BIOTECHNOLOGIES, LLC · Z6JDHSB4HXZ5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- GALEN BIOTECHNOLOGIES, LLC · Z6JDHSB4HXZ5
- Awarding agency
- Department of War · sub-agency 9763 · office S0507A
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- HDTRA113C0061
- Award type code
- D
- Actions
- 4 · Sep 30, 2013 to Oct 25, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Oct 25, 2019 | FY2020 | A00002 | C | −$15,351.13 | — |
| Aug 7, 2014 | FY2014 | P00002 | B | $77,571.01 | — |
| Jun 24, 2014 | FY2014 | P00001 | B | $6,971.00 | — |
| Sep 30, 2013 | FY2013 | 0 | — | $488,968.86 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.